نتایج جستجو برای: avian reovirus

تعداد نتایج: 42768  

Journal: :Journal of bacteriology 1966
C Wallis J L Melnick F Rapp

Wallis, Craig (Baylor University College of Medicine, Houston, Tex.), Joseph L. Melnick, and Fred Rapp. Effects of pancreatin on the growth of reovirus. J. Bacteriol. 92:155-160. 1966.-The influence of pancreatin and other proteolytic enzymes on the growth, plaque formation, and antigenicity of reovirus was studied. Single-cycle yields of virus in the presence of enzyme were not increased, but ...

Journal: :Molecular therapy : the journal of the American Society of Gene Therapy 2016
Karishma Rajani Christopher Parrish Timothy Kottke Jill Thompson Shane Zaidi Liz Ilett Kevin G Shim Rosa-Maria Diaz Hardev Pandha Kevin Harrington Matt Coffey Alan Melcher Richard Vile

Oncolytic reovirus can be delivered both systemically and intratumorally, in both preclinical models and in early phase clinical trials. Reovirus has direct oncolytic activity against a variety of tumor types and antitumor activity is directly associated with immune activation by virus replication in tumors. Immune mechanisms of therapy include both innate immune activation against virally infe...

Journal: :The Journal of Experimental Medicine 1987
S D London D H Rubin J J Cebra

In this report we have shown that reovirus 1/L is an effective mucosal immunogen capable of generating a cytotoxic T cell (CTL) and associated helper T cell response to the nominal antigens associated with reovirus 1/L. The effectors that mediate reovirus-specific cytotoxicity are Thy-1+, Lyt-2+, and major histocompatibility complex (MHC)-restricted in their recognition of reovirus antigens, an...

2017
Yusuke Inagaki Eiji Kubota Yoshinori Mori Mineyoshi Aoyama Hiromi Kataoka Randal N. Johnston Takashi Joh

Imatinib, a multitargeted receptor tyrosine kinase inhibitor, is used as the standard initial therapy against inoperable gastrointestinal stromal tumor (GIST). However, GIST can acquire resistance to imatinib within several years of therapy. The development of oncolytic reovirus as an anticancer agent has expanded to many clinical trials for various tumors. Here, we investigated whether reoviru...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2015
Victoria Roulstone Khurum Khan Hardev S Pandha Sarah Rudman Matt Coffey George M Gill Alan A Melcher Richard Vile Kevin J Harrington Johann de Bono James Spicer

PURPOSE Reovirus is a wild-type oncolytic virus that is ubiquitous in the environment; most patients are therefore preimmune. Therapeutic administration leads to an increase in neutralizing antireovirus antibody (NARA) titer. We hypothesized that if NARA limited reovirus antitumor activity, the effect might be attenuated by coadministration of cyclophosphamide. EXPERIMENTAL DESIGN In a phase ...

Journal: :The EMBO journal 2000
M Shmulevitz R Duncan

The non-enveloped fusogenic avian and Nelson Bay reoviruses encode homologous 10 kDa non-structural transmembrane proteins. The p10 proteins localize to the cell surface of transfected cells in a type I orientation and induce efficient cell-cell fusion. Mutagenic studies revealed the importance of conserved sequence-predicted structural motifs in the membrane association and fusogenic propertie...

Journal: :The Journal of Experimental Medicine 1982
J T Nepom H L Weiner M A Dichter M Tardieu D R Spriggs C F Gramm M L Powers B N Fields M I Greene

A xenogeneic antiserum raised to antireovirus immunoglobulin was used to define an idiotypic determinant present on antibodies to reovirus type 3 hemagglutinin. The same idiotype was identified on nonimmune lymphoid cells and on neuronal cells that specifically bind the hemagglutinin of type 3 reovirus. This idiotypic determinant, called Id3, is shared by (a) a monoclonal antibody to the neutra...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید